
U.S. regulators opened a 60-day Title VII review of swaps and emerging products as CME challenges the CFTC’s approval path for retail-focused perpetual futures-style contracts with implications for crypto markets.
The U.S. Securities and Exchange Commission and Commodity Futures Trading Commission launched a joint public comment process on whether existing derivatives definitions under Title VII of Dodd-Frank still fit swaps, security-based swaps, mixed swaps and novel or emerging products. The review comes as CME Group challenges the CFTC’s approval of retail-focused perpetual futures-style contracts for event-contract platforms including Kalshi and Coinbase, sharpening a dispute over whether contracts without expiration dates and with periodic funding mechanics should be treated as futures or swaps. That classification affects clearing, margining, venue approvals, reporting obligations and competition in U.S. derivatives markets, including for crypto-linked products. Hyperliquid Policy Center CEO Jake Chervinsky criticized CME’s lawsuit as a “shocking misjudgment” and an “unforced error,” while commentary cited in the source said CME may have a strong argument, though that is not a court ruling. The comment period is expected to run for 60 days after publication in the Federal Register.